Kadcyla 100mg Injection
Marketer
Roche Products India Pvt Ltd
Salt Composition
Ado-trastuzumab emtansine (100mg)
Overview Kadcyla 100mg Injection
Trastuzumab emtansine 100mg injection treats both early and advanced breast cancer. Specifically, it targets HER2-positive breast cancer that has metastasized and failed prior therapies. Administration is strictly by injection from a qualified healthcare professional, with dosage and frequency determined by your physician based on your individual condition and potentially adjusted over time. Adhere precisely to your doctor's instructions; incorrect usage or overdosage risks severe adverse effects. Therapeutic benefits might take weeks or months to manifest; discontinue only under your doctor's guidance. Common side effects include fatigue, nausea, musculoskeletal pain, and hemorrhage. This medication can lower blood cell counts (red and white), raising infection risk. Regular blood tests monitoring blood cell levels, along with heart, liver, and uric acid levels are essential. Inform your doctor of pre-existing heart, liver, or kidney conditions, or any infection treatments before starting this medication. Interactions with other medications are possible; fully disclose your medication list to your healthcare provider. Pregnancy and breastfeeding are contraindicated; reliable contraception for both partners is crucial during treatment. A patient support/assistance program exists in India, facilitated by Tata 1mg; inquire with your physician or call 1800-102-1618 for details.
Uses of Kadcyla 100mg Injection
Breast cancer (early stages) | Advanced breast cancer
Major Benefits of Kadcyla 100mg Injection:
The medication will be administered by your physician or their associate; self-medication is strongly discouraged.
Common Side effects of Kadcyla 100mg Injection:
- Tiredness
- Nausea
- Musculoskeletal (bone, muscle or joint) pain
- Bleeding
- Low blood platelets
- Headache
- Liver disorder
- Constipation
- Nosebleeds
How to use Kadcyla 100mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Kadcyla 100mg Injection works:
Trastuzumab emtansine 100mg injection is a medication used in cancer treatment. By targeting HER2 receptors on breast cancer cells, it marks these cells for elimination by the body's natural defenses. Furthermore, the drug enters the cancerous cells, delivering the chemotherapy agent emtansine to inhibit their growth and replication.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Kadcyla 100mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Trastuzumab emtansine 100mg injection poses a confirmed risk to a fetus and should not be administered during pregnancy. In exceptional, life-threatening circumstances, a physician may deem its use necessary if the potential benefits outweigh the known dangers. Physician consultation is essential.
Breast feedingUNSAFE
Trastuzumab emtansine 100mg injection is contraindicated for use while breastfeeding due to the potential for infant toxicity.
DrivingSAFE
Driving ability is typically unaffected by Kadcyla 100mg Injection.
KidneyCONSULT YOUR DOCTOR
Data regarding Kadcyla 100mg Injection use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCAUTION
For patients with severe hepatic impairment, administering Kadcyla 100mg Injection requires careful consideration. Dosage modification of Kadcyla 100mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Kadcyla 100mg Injection :
Should you forget a Kadcyla 100mg Injection, contact your physician for guidance.
Facts to Know About Kadcyla 100mg Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Good Habits | No. |
| Treatment Category | Cancer Therapeutics |
| Action Class | Monoclonal Antibody HER2/neu (ErbB2) Inhibitor |
3,018 People bought this recently